Truist Securities Reiterates Buy on Exelixis, Raises Price Target to $33
Portfolio Pulse from Benzinga Newsdesk
Truist Securities has reiterated its Buy rating on Exelixis (NASDAQ:EXEL) and raised the price target from $32 to $33.
August 08, 2024 | 12:36 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Truist Securities has reiterated its Buy rating on Exelixis and raised the price target from $32 to $33.
The reiteration of a Buy rating and a slight increase in the price target from $32 to $33 by Truist Securities is a positive signal for investors, indicating confidence in the company's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100